ILIU Financials 07/16/2014 10:14:47 Interleukin G

ILIU Financials 07/16/2014 10:14:47
Interleukin Genetics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,430 2,236 2,857 1,997
Cost of Revenue 1,632 1,329 1,527 1,619
Gross Profit 797 908 1,330 378
Operating Expenses
Research and Development 722 1,312 1,376 1,414
Sales, General and Admin. 6,565 4,151 4,665 5,053
Non-Recurring Items - - - -
Other 109 115 115 115
Operating Income (6,599) (4,670) (4,827) (6,204)
Income From Continuing Operations
Add'l Income/Expense Items 13 4 11 38
Earnings Before Interest and Tax (6,586) (4,666) (4,817) (6,165)
Interest Expense 472 454 367 303
Earnings Before Tax (7,058) (5,120) (5,184) (6,469)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,058) (5,120) (5,184) (6,469)
Non Recurring Events
Discontinued Operations - - 158 483
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,058) (5,120) (5,025) (5,986)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,058) (5,120) (5,025) (5,986)